top idea rais po
like anoth year out-performance
host call diabet expert erik verhoef presid seagrov partner
reinforc view also due dilig give us increment confid
growth potenti beyond due dilig
area find cgm could potenti use increas
appreci dxcm competit moat dxcm stock
think could outperform remain bullish street estim
remain low view stock like work year-end launch
expect potenti libr approv major neg come
win prefer payer agreement out-of-pocket cost quickli
narrow libr think also abl turn dtc
advertis manufactur capac expand updat model rais
po base sale vs prior given
increas confid revenu growth upsid reiter buy rate
takeaway seagrov diabet expert call
key takeaway see insid full transcript well select
market data recent publish seagrov partner diabet book
market size core may bigger current think base case
cgm core intens patient basal/bolu insulin
seagrov see earli adopt think cgm also applic
patient basal insulin suggest core market opportun cgm
could closer patient instead data readout
out-of-pocket cost libr close seagrov larg patient
survey latest survey show out-of-pocket cost libr
roughli equival bullish view
seagrov believ cgm beyond core market littl use cgm
beyond core intens market potenti market appear quit
excit year non-cor onduo data posit gestat diabet
hospit seem ripe cgm uptak mani analyt beyond glucos
studi could also measur cgm-type sensor
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
net dbt
dtc direct consum
return capit employ
return equiti
dexcom inc oper medic devic
compani focus design develop
continu glucos monitor cgm system
peopl diabet compani
develop small implant devic
continu measur glucos level
subcutan tissu skin real-tim
data process display patient
also alert level high low
product market physician
endocrinologist diabet educ
see sever avenu beat street
estim near term long-term penetr
non-intens type patient popul
increas total avail market opportun
also believ cgm remain top-tier
growth market patient adopt cgm
beneficiari tailwind
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
tabl bofa cgm model assumpt million
us patient
us patient
us patient
total us patient
penetr patient intens pop
bofa research adjust calendar year
highlight main takeaway confer call erik verhoef
seagrov partner mr verhoef market expert diabet view
inform seagrov partner proprietari survey focu group conduct
patient payer well leverag relationship diabet industri
full transcript detail thought outlook cgm
insulin pump market descript sever cgm start-up compani
discuss upcom data releas catalyst patient focu group result
market size core market may bigger current estim
base case cgm intens patient basal/bolu
insulin earli adopt doctor think cgm potenti applic
patient basal insulin suggest core market opportun
cgm could closer patient instead penetr market
today data requir broad payer coverag adopt
number studi on-going read
cgm beyond core market today littl use cgm beyond core
insulin intens market potenti cgm next year
market appear quit excit larg untap opportun posit data
publish recent onduo patient show potenti cgm much
larger non-cor type space gestat diabet hospit environ seem
ripe cgm uptak view patient risk diabet admit
hospit could get cgm instead nurs multipl finger stick/blood draw per
day sensor could also use beyond glucos measur post hospit discharg
sepsi risk mani analyt beyond glucos diabet
studi could measur cgm type sensor
pocket cost libr close seagrov larg patient
survey out-of-pocket cost move lower patient time
move pharmaci channel gain prefer payer agreement
latest survey septemb first time pocket cost
libr roughli equival bullish view given
pushback patient would choos libr lower price
made signific progress lower price make
volum side view
could rebirth diabet seagrov consum survey work
suggest show data time rang earli
commun possibl start stabil pump
share loss given score earli survey work even compar control-
iq horizon ad mdt custom doctor support may enough
patient stay despit disadvantag cgm side
requir fingerstick seagrov view also potenti would
meal-correct bolu advanc control-iq correct bolu
featur could addit sell featur time tell real
world experi play given recent share trend
need deliv view see transcript
start cgm compani may abl help longer term well
new head diabet could potenti outlin plan thought mdt diabet
busi januari think new head diabet like enough confid
pipelin partner like scenario
market could acceler next year penetr ultim top
around seagrov expect pump market acceler
potenti new pumper come market vs estim
slightli higher believ start pump seagrov believ
coupl year pump penetr start peak around growth
market start flatten smart pen futur competitor would like also
transcript call erik verhoef
bob hopkin okay thank morn everybodi bob hopkin along
partner travi steed know everybodi know call morn
talk diabet get start want reiter relev
disclosur pleas read invit note went last week advertis call
think everyon know diabet arguabl import market
medic devic right one four market medic devic
market billion dollar grow doubl digit addit sole
driver tandem diabet singl import product
abbott incred given size abbott one product drive
well growth entir compani diabet clearli
import driver abbott would argu also margin one
import product area even though revenu
busi probabl one greatest potenti
variabl result therefor diabet critic market well
especi sinc brand new head diabet think like hear
new head diabet earli januari updat strategi
diabet group
today thrill erik verhoef line us today erik founder
presid seagrov partner diabet consult firm erik travi
known sinc tandem went public met erik
process creat consult firm think best work
diabet erik incred partner us id encourag everybodi visit
seagrov websit think erik real thought leader space
phenomen work erik thank much us today
bob hopkin thought ye absolut get start erik think itd
help everybodi kind give peopl sens histori
background come histori seagrov would
great place start well get
erik verhoef sure healthcar year start
hospit space consult eventu move sell-sid
analyst cover healthcar pharmaceut stock spent number
year pharma glaxosmithklin bristol myer market role
end back hometown san diego work biosit eventu
diabet care space tandem
mention went fundrais ipo tandem
spent nine year start seagrov three year ago
main focu today diabet weve also recent launch oncolog platform
pretti much syndic report
cover variou topic whether cgm pump pharma publish someth
pretti much everi month certainli keep us busi
bob hopkin ye bring uniqu insight payor side
consum side lot good work that done
structur call morn attack diabet devic market
today go start discuss cgm move pump
categori well start thought market move
thought market share realli tri get understand thought
outlook beyond growth market competit
travi obvious primari respons tandem ill
hand travi kick cgm side sinc
travi dont get convers go well chime
good discuss
travi steed great thank bob thank morn erik im realli
look forward convers realli want start like bob said start
market start kind level set think cgm
market look type specif move type ii intens
think total market level set thing type think
penetr today think growth think
penetr growth type market cgm
erik verhoef ye ye model im probabl littl bit higher
denomin may see model number type
ive got almost million recent report put ive
got total type cgm user give penetr
think still way go research suggest pretti much hcp
healthcar provid want put type cgm cours that
realist given insur there alway go patient dont want wear
extra devic
model penetr year goe low
market growth impress kind
go forward put pretti conserv number think
type space doesnt includ discuss gestat
diabet hospital-bas diabet conserv strip
model core type growth next year
travi steed alright great mayb convers type ii
intens growth think penetr chang
last year chang next year
bob hopkin level set talk
get right
bob hopkin want make sure delin world-wide
 number also dive mayb take one quick step
back explain process work come number
obvious public disclosur know lot work
help us understand process come number well go
back weed
erik verhoef ye thank ye littl difficult get current base cgm
there partial disclosur abbott good job say total
world-wide number well period know
sinc given disclosur kind back your given
piec theyv given revenu model well survey
patient hcp figur percent type type ii use cgm
kind triangul approach come number
bob hopkin great sorri interrupt thought import get
background think travi ask type ii
travi steed type ii intens patient cgm think market growth
last year next year
erik verhoef ye type ii space kind model say total type ii
right pretti much intens separ line item
insulin use would peopl basal basal bigger
market given growth last year that mostli
libr think theyr disclos sale type versu type ii
point grow steadili growth
model almost growth space conserv type ii
look penetr million peopl right
type ii insulin requir kind penetr rate
thing kind get excit space there number
studi think abbott im sure
clinic studi realm look basal-onli basal-bolu type ii effect
cgm use blood sugar control go start read
next year that realli need get payor move get
payor coverag get hcp excit put type ii cgm
anecdot talk hcp theyll tell littl unsur
put somebodi libr type ii realli got
engag diabet pretti transform either profession
version libr person version im excit see studi whether
theyr attd advanc technolog treatment diabet februari
madrid later ada american diabet associ chicago think
go import model real penetr could given
today insulin-us market
travi steed much think type ii penetr chang
catalyst realli get payor board someth patient
popul that go take littl longer also think type ii
get penetr wherev type
erik verhoef dont think well get model popul
close penetr still big given larg patient
popul dwarf type think ive alway one peopl
say treatment type ii realli kind paternalist focu
group type ii theyll tell nobodi talk insulin pump
nobodi talk realli abbott take lead
direct consum advertis get peopl knowledg hey dont
finger stick anymor
bring focu group see look face theyr
like tell product get right kind
trickl doctor patient think least start see
outcom studi come think drive physician push think
direct consum advertis go realli import dont think
patient pushback thing think patient realli interest especi get
wear finger stick
market think could get penetr
 basic like recreat entir type cgm launch year ago
kind talk type ii popul look
model everyth term variabl one right
penetr group could easili
import denomin look individu compani growth abbott
travi steed want cover think said million patient get
number think peopl think type ii intens closer
million million differ million
applic cgm
erik verhoef ye million insulin requir insulin intens
insulin intens actual million think million reason ive got
model put way get number take sale number
variou insulin whether long-act rapid act make
assumpt okay well much cost individu patient
year look net price figur discount rebat well
complianc individu product come
annual cost adjust patient divid revenu come
number patient
throughout process total insulin requir type ii popul
million insulin intens million think fair game cgm
mean entir million pump side that case think theyr
go million cgm talk
kind earli adopt hcp theyr realli make distinct insulin
intens insulin requir theyr put basal patient
cgm realli think requir mani finger stick theyr per
day somebodi one finger stick day period week
theyr probabl candid cgm point theyr test two
three time day theyr look replac cgm product think
itd great could figur libr sale exactli mani
insulin requir versu basal patient feel like fair game includ
million part model
travi steed that help thank put togeth
think cgm growth total market next coupl year
also id love hear thought think market realli acceler
way grow basic realli huge chang
growth market last year love hear thought
sustain think
erik verhoef ye one thing want add type ii space
think drive growth tv ad kind go doctor
offic lot fact abbott databas million
peopl old freestyl bgm think low-hang
fruit abl directli market theyr databas
say hey great test weve got better product dont
finger stick think lot convers rel easi
think look futur weve got number new entrant
old meter compani like like agamatrix like lifescan come
despit fact may perfect product term factori
calibr go differenti point product either
eas use better reader someth importantli
databas current custom market role think acceler
lot growth type ii space
think weve seen either type type ii past year two
increas reimburs medicar coverag come
earli abbott got factori calibr accuraci becom almost
kind almost standard around level wherea kind make
equival view finger stick use mard
lot question accuraci weve kind like
coalesc rang actual better mard
think kind shift away clinic argument
everybodi bought use accur machin engag custom
lot frequent test see direct result theyr
eat exercis whatev shift kind like
pump slim make consum friendli
make wearabl make action daili
basi download data better peopl follow share
becom switch medic devic think
consum devic outer year think help argument non-
diabet applic cgm well
travi steed term growth think growth rate go
total cgm market
erik verhoef total cgm let see
bob hopkin
travi steed ye
erik verhoef ye total cgm abbott
ive got that realli
assum theyd sensor come total type
growth type ii growth
travi steed alright great that help overview market want ask
your think share dynam two compani
captur new patient market becom penetr today youv got
compet libr potenti libr come point next
year come late next year patient type type ii
devic best think share
two chang libr come januari versu later
year
erik verhoef ye kind earlier think bullish libr
get summer approv theyd higher back year realli push
type space think may given opportun look
contract look reimburs get creativ
price thing think recent survey weve done
weve specif ask patient what pocket cost libr versu
right latest survey septemb theyr equival
compar last year libr definit lower end compar
think mean variou mean whether coupon program
aggress contract payor start answer cost
dispar question survey libr directli either
see type space realli built brand
equiti hcp patient matter kind put front
survey alway tend prefer product libr move
needl littl bit youv ad alert alarm think
peopl realli say okay get like product cheaper
add mix specif say go
competit pariti cost product libr sudden peopl
went libr like oh okay im go go back
day there transmitt go flatter like libr cours
go lower co-pay
reason score well weve done analysi six differ patient
group five six demograph across type type ii realli
brand equiti that built answer kind
neg thing peopl look either rel libr
think that go realli transform product import
thing allow get type ii space know right
minim penetr abbott kind domin
market share wise think go dont see big share shift
total market share abbott
that close take littl bit share
go risk model kind share kind even
two player there lot room growth realli come
market type ii patient tri push
differenti that market opportun go
type term penetr go next year
kind close total penetr rate type growth
least realli go come type ii space think heavi
lift compani term reimburs
clinic studi go pay come market thing
that go pay know manufactur constraint
compani demand high ad addit
manufactur line kind address issu today take hit
margin theyr go lot better posit even explos
growth demand next coupl year
bob hopkin hey erik one thing your talk prefer
realli know right mention survey work
mayb could describ littl bit
erik verhoef ye way describ goe day think
that import peopl think sensor would even better that
someth metronom pursu kind keep calendar
need two sensor month three day youv got
find third sensor think day import think get rid
transmitt realli import make whole thing dispos make
flatter cours manufactur cost allow get closer
per day kind cost
look libr today that incorpor cost
transmitt current cost think theyr quit bit per day
thing know im sure there improv
accuraci like clinic thing look think least
today abl make argument pretti effect
dont think patient realli appreci look low end
spectrum high end spectrum variou accuraci
measur need standard icgm think import
hcp get think libr come help abbott
think market right get win use
icgm argument
travi steed featur libr type would
reason type prefer libr icgm cgm today
erik verhoef wouldnt say small group larg group let say
decent size group type dont like forc alert
alarm get alarm fatigu theyr theater dont want risk
alarm go theyr busi meet someth like
understand libr theyr option alert alarm
want use especi night think import part
kind alarm go child asleep your asleep think
that import part option abil would like
person use cgm
travi steed make sens mention plu growth
cgm dont know your includ stand-alon guardian connect
small base your includ total cgm im curiou come
conclus think fact still finger stick issu
patient burden patient
erik verhoef ye that great question think growth rate
there small base right mostli driven expect
kind provid renew growth busi well
stand-alone realli havent seen lot use survey even sugar iq
think good product attach sensor realli
go low base get better growth think
calibr issu right kind go argument
calibr import especi order drive close-loop system
think latest survey peopl buy one two calibr
import lot peopl libr peopl survey
calibr day someth theyr use
peopl arent even theyr kind use
calibr kind translat daili life want make sure
sensor work way properli way get four
five calibr day peopl say littl
much there option zero calibr
think least near term still go
calibr cut half two think least
pump market peopl buy need drive system give
better time rang allow potenti skip meal without bolu
think compel argument core cgm user that pump
put give libr calibr market stuff see
around put guardian requir calibr
sellabl argument youv got tie pump perform
travi steed ye that help dont know thought libr
havent gotten approv yet delay mayb your like rest
us guess thought id love hear also
want go medicar opportun well sinc move
last coupl month thought size opportun
penetr think share libr medicar
erik verhoef ye havent let start latter havent model
specif space anecdot ill tell focu group
get lot medicare-ag peopl theyll rais hand say
know medicar isnt pay libr peopl around tabl like oh
ye sudden youv made potenti custom
libr custom focu group like saw omnipod get
medicar coverag realli big market especi type ii space
almost let call medicar
open combin stuff
talk term clinic trial variou argument plenti
type ii insulin-requir patient cgm import add medicar
compon ive said realli big requir get growth
expect next coupl year question libr total
specul part dealt fda previou live particular
depart use product
small group peopl kind review cgm
pump smart pen right lilli smart pen kind
held tandem control iq held libr held im sure theyr
review data time term theyr
review theyr review clinic trial result theyr review binder
binder softwar data risk mitig calcul strategi that
realli focu theyr like want identifi potenti
hazard product give us answer algorithm
mitig risk
take lot time go that point number one
think resourc restraint point number two point number three especi
pump cgm space product rel new term technolog
algorithm theyr use math that involv think take
might even appropri expertis evalu that autom
correct bolus potenti autom meal bolus that actual done
math that requir icgm standpoint think nice
agenc say hey standard meet standard get
obvious that realli happen think mayb might second-guess
complic put page standard
meet your done think combin three
factor ive mention see delay
bob hopkin interest let jump one second topic erik
perspect dont see major reason concern
delay given everyth went think
there chanc there someth littl bit neg go
erik verhoef complet conjectur part think fda-level
stuff tandem lilli abbott product-rel thing
bob hopkin ye help perspect compani fyi
everybodi call tandem halt well see that
shortli im sure one thing want ask cgm side
go back travi medicar think big pictur cgm abil
compani beyond creat truli accur devic good
know littl bit specul point what view gener
speak whether compani whether libr stuff
talk long term what level confid compani
year failur abl come someth that equival
erik verhoef ye think think think realli smart peopl
around tabl abbott group ive alway said peopl
im go hire peopl
manufactur figur think come manufactur
expertis obvious math algorithm that ahead think theyll
get problem kevin sayer probabl alreadi think dexcom
point
great product feel bad peopl team
everybodi kind shift focu year launch
think thing go happen team
aggress think next gener technolog make
better theyr alway go lead time rest compani
that kind short answer im expert math manufactur
think that realli secret sauc
travi steed alright thank erik move pump
there lot talk love get thought think
cgm move beyond core market market goe
busi model look like payor perspect go risk
abbott pay sensor dont know saw
onduo publish data coupl day ago type ii patient look realli
good promis id love hear thought opportun
erik verhoef ye ye love fact onduo actual publish real data think
that realli kind differenti diseas manag
compani think mayb focu
sanofi kind pictur know term sat
kevin sayer ada last year ask non-diabet
applic realli focus big type market peopl
without diabet could use interstiti measur get thing like
post-discharg sepsi risk think peopl discharg
hospit that one number one thing theyr concern
get infect that get ton antibiot leav
hospit think lot peopl would wear sensor least week two
week monitor risk monitor interstiti fluid that blood
sugar your monitor analyt
kevin sayer realli focus like gestat diabet
hospital-bas stuff kind tune said look
later look pregnanc gestat diabet
would easi market put somebodi sensor least mid-
term pregnanc probabl like month four five way
monitor risk gestat diabet think larg market
think get lot peopl actual get diseas
probabl look pregnanc concern
risk
think massiv market even though market theyr go
use product throughout rest life certainli obvious
continu market term number pregnanc happen everi year
in-pati side term number peopl diabet need
blood sugar monitor theyr hospit also larg right
abl monitor blood sugar happen sensor mainli
sensor link hospit kind monitor system
that one easi think easi market figur
get sensor data bluetooth kind
intermediari devic get onto hospit system lab coordin
see pretti much anybodi who risk diabet known
diabet get admit hospit automat stick sensor
think would make life lot easier nurs either draw blood
right take finger stick monitor blood sugar
think kevin sayer right money look kind
easi win next coupl year youv got pure non-
diabet applic think real look peopl wear appl
watch fitbit kind thing go away keep
grow peopl look differ analyt everyth monitor
health know peopl around san diego dont diabet wear libr
heck see what happen blood sugar
travi steed that great discuss want move insulin
pump run time
bob hopkin hey travi hold one second want one thing cgm
question two question competit landscap long term obvious
right two main compani pump could
highlight view new competit come cgm mayb say next
two four year importantli may specul
id love view anyway
theyv got new individu run divis yet
speak publicli thought new strategi go forward would
imagin one import thing inform decis whether
think pipelin includ cgm match
accuraci even coupl year away come conclus
dont technolog hous there kind
strateg possibl includ partner partner one
smaller player guess two quick thing one reason
optimist medtron abil make accur truli accur competit
sensor number two mayb quickli mention view
competitor your track cgm space longer term
erik verhoef ye ye ye realli good question think sens right given
theyv long time first cgm that
dont think intern expertis match even abbott
point think probabl think theyr much advanc pump
side algorithm theyv kind
hand tie behind back sensor technolog number new
competitor could bring hous better product
ill mention metronom one compani laguna hill
rel close san diego think theyr pretti close abl
pivot trial next year theyr look commerci europ first
 second half thing wear low cost
manufactur around equival accuraci better adhes
easier use insert kind make whole cgm thing human factor
orient differ type technolog wont get
think privat compani that probabl easi take-over candid
somebodi like new player come kind old meter
compani like lifescan ascensia agamatrix three think use
exist instal base tri sell theyr kind come weve
got better insert differ angl less pain dont think
mard go anywher near libr requir
calibr point theyll figur theyll market
anoth one that interest nemaura product call sugarbeat
cgm that avail eu non-invas patch mard
rel poor daili patch slap
patch insert anyth bodi there go patient
popul that go want pretti much everi one
mention alreadi approv europ think except lifescan
well see kind perform european market right
domin libr come definit would say
pay attent player theyr rel experienc compani diabet
good see there go option patient
bob hopkin great thank that help sorri travi think
go pump
travi steed alright perfect pump littl bit differ dynam there
realli two thing share guess actual import pump today cgm
late growth come share shift compani leav
space realli seem like market also start acceler love get
thought start market today penetr thought
share number compani think growth pump
erik verhoef ye ye right like total type type ii market
wonder chang model easi number
rememb kind kept way type number
ive got type ii growth type space
equival type ii what realli realli drove growth know
anima exit market peopl look home whether
omnipod tandem tandem got lot growth group
cours tandem integr pump
year last year anima way that big argument
patient talk hcp survey realli provid
tandem great opportun go anima patient also
medtron patient think even though lose patient medtron
may big deal instal base tandem big deal
key thing think realli interest pump space compar
perfect storm posit thing allow tandem grow
way think almost neg neg storm control iq
delay let say get approv today public said theyr
go launch product approv could three four-
week field train hcp impli there go
control iq ship quarter
coupl said peopl delay purchas
basal iq didnt want train two differ product mean
think theyr look pretti soft number tandem question
well kind demand happen think lot peopl
deduct get reset sudden shell
wouldnt realli depend plan plan allow
leak januari deduct
lot peopl think go say expens go
hurt opportun could gotten like septemb
approv thing happen youv got youv got
come let say may theyr present data spain februari
attd confer data posit even calibr requir theyr
abl say weve got plu time rang theyr kind indic
weve got kind super autocorrect bolu miss meal
actual go pick correct
would view look product say im will calibr go
give much better control think lot hcp go kind
look market kind freez product come
product come cours upgrad program
back end year youv got omnipod
horizon come survey data say best product phone
control integr nice algorithm
adjust set point tri keep
thing think tandem specif go creat market
freez go thaw go freez
go compar great comp
think may actual potenti neg growth quarter way
year compar think go
challeng tandem think benefit much
sensor think im hear im expect
deliv ada spain confer realli go revit divis
omnipod keep truck along horizon come think
put pressur well tandem
go interest market think probabl biggest data
im look spain present pivot trial result think that
go realli well-attend session think realli import peopl see
data that realli go drive lot first half year sale
travi steed ye go question look like
tandem got control iq approv fda realli first integr
interoper autom insulin-dos system anyth
look label fda document would chang anyth
think approv
erik verhoef ye ye would realli interest dont front
see control iq also auto-correct bolus mean
havent blood sugar let say your manual say give
extra insulin go pick cgm automat
first product that go want see label
say think sinc theyr telegraph
go algorithm good actual miss meal
kind next level import actual correct bolu correct
id want see label actual say
miss meal bolu correct versu whatev weve got label
control iq think whole autocorrect bolu probabl key thing id
look
travi steed okay control iq go take
coupl week get market realli next year stori
tandem seen littl bit paus littl bit littl bit
view enough bring patient back adopt tandem pump littl
bit wait deduct reset next year see littl
bit extra growth control iq approv know tandem
busi acceler basal iq go see kind similar acceler
control iq
erik verhoef think definit your go better normal think
your go realli poor think peopl may littl surpris soft
turn number come april whatev theyll
probabl decent quarter depend data
realli good plu know control iq
think your go lot physician say like like pretti close like
wouldnt surpris result control iq approv actual lot less
peopl expect know product lot peopl look
forward everyth know peopl wear trial
situat like everyth peopl said like
product clinic trial format ye hard one call think
one call rel easier base comment
tandem kind put public would expect soft quarter
travi steed ye think tandem alreadi said would line street
dont think anyon expect beat doubt would miss
expect theyv set coupl week ago
bob hopkin hey travi let jump real quickli want follow-
erik comment omnipod know youv done lot work
erik relat sort respons differ payment model exist
mayb comment littl bit folk your consum
research shown rel import differ payment model
erik verhoef ye ye pay go model think realli import
commerci popul also medicar popul omnipod
go patient say there up-front cost buy month
pod there commit dont buy year worth pod see
like that compel argument somebodi versu tandem
shell four-year kind deal
thing that think that interest tandem look
renew rate right peopl product theyr kind
renew four year theyr like that think
probabl plu term renew tend sticki product
your shell money dont want get rid think that
issu tandem address wherea omnipod renew
your buy monthli pod without commit that much
easier someth somebodi stomach theyr patient
type ii side think realli like model there
dispos element within medicar rule go pharmaci
channel dont need c-peptid test theyr get product approv
type ii wherea medicar somebodi like tandem
cancel flex product couldnt get reimburs
way code that go help omnipod
type type ii space allow like much
predict growth pattern dont tend lot season up
like deduct reset
second half year your abl say think
get approv pump control via phone that
big deal that go realli big deal market combin
integr think go one better
algorithm alreadi pre-pivot studi skip
went directli pre-pivot right theyll wrap pivot think
februari next year theyr set second half launch product
potenti data whatev show ada next year think
import well
bob hopkin thank one thing hand back travi
erik okay go anoth minut okay
bob hopkin great great big pictur question pump
diabet busi gener way commun
street roughli speak think diabet diabet busi
grow mid-singl digit right busi shrink
think im hear answer youv discuss
think one realli import question go interest
enough help stop bleed mayb heard
kind depend data view question
erik verhoef ye mean histor know ive fairli critic
big fan divis think think
perfect time sean salmon kind take control divis he got
easi comp compar major product launch think
whole compani go behind im pretti impress result im
get patient survey work put
control iq horizon
least current instal base kind like well know
seem pretti compel may stick versu last year
talk control iq versu saw lot peopl want switch
tandem think go help keep instal base
come data even high time rang think that
big enough delta your go get lot peopl stick product
lot hcp think that compel enough kind go back mother
peopl still realli appreci support get patient still
appreci fact lot co-pay assist program make
lot afford whether alway kind
good let say data inde dont see
compani point reintroduc calibr mix
kind match near term that go big market advantag
well im call uber correct bolu kind
interven whole bunch differ situat
think im sean salmon im pretti posit growth rate dont think
there chanc youd see much launch kind paramet
there go continu neg growth divis think realli
rebirth diabet
travi steed lot data actual product
perform real world get patient hand like
data good littl issu perform kick
patient auto-mod think lot peopl actual come
sensor sensor realli chang id love hear
think there disconnect data actual perform product
chang
erik verhoef ye your right sensor
also algorithm wherea think adjust algorithm
theyr alreadi talk that improv dropout rate
kind carryov ye real world data also appli control iq
realli individu kind patient input
requir get system kind work properli that someth
kind jump subject realli like compani like beta bionic
say patient input requir get
autom system kind negat purpos autom
beta bionic requir patient weight algorithm set
insulin carb ratio set sensit factor differ thing need
set current manual pump compani that
autom system algorithm learn cours week first use
therer patient input need make life lot easier rather
announc your eat announc your exercis
littl announc system
your absolut right real world use import patient lot
come train peopl product theyr one front
line problem take data fix
said pure sale perspect data plu
go freez market ive freez
tandem pretti know theyr definit affect
individu rep that field tri meet quota pump
month whatev
travi steed ye alright that help want go back littl bit market
know got littl bit distract control iq approv current think
patient move mdi pump
that acceler new product come next
year horizon tidepool think patient acceler
patient move mdi pump think ultim penetr
pump type popul would like
erik verhoef ye ye question dont know term addit peopl
go pump think like term total pump im type
type ii im look peopl within type specif number
ye that realli come
peopl fenc right theyr look autom
system theyr look someth like horizon eventu im get
growth next two year kind flatten penetr
type market flatten reason doesnt go
there lot peopl dont want wear two devic
theyr go pick cgm first first devic wear your
go ask put either pod infus site bodi second site
dont want either cosmet reason develop scar
tissu time your doubl acceler scar tissu wear
two devic youv got top smart pen come whether
companion medic lilli novo bigfoot biomed etc product
essenti make argument dont need separ site bodi
cgm integr pen algorithm go
get way term benefit pump therapi
current pen give flexibl like pen peopl
dont know diabet wear pump your kind
control argument kind come side challeng
pump growth there group peopl candid
system unless someth like beta bionic im talk
dont anyth
lot patient even type think theyr like super motiv
whatev there big group take insulin
dont die get engag onto autom
system wear belt wear bodi there
data that shown hcp dont want
dont even want admit theyr diagnos diabet theyr kind
grappl
feel like wear devic remind everi day theyv
got diabet there alway go group peopl dont want
wear pump that kind flatten thing close term
penetr
travi steed okay pod start make littl bit progress
type ii patient popul itd great hear think market develop
penetr goe type ii pump kind
opportun tandem pump compani abl
make headway especi sport come later
erik verhoef ye dont think sport go much type ii product
said reimburs model go slim
would make hard get reimburs pure
dispos product like omnipod valerita v-go order make argument
get special code allow go medicar commerci
plan follow tend follow medicar rule type ii pump approv
think sanofi get market plan type ii
patch pump realli market come valerita omnipod
cequr anoth one kind look bolus-onli patch pump
pure manual kind nice design click get two unit per
click that suppos launch kind time meantim ye
omnipod uniqu model abl add
concentr insulin test weve done market research that kind
win one v-go second place one that nice easi use product
day applic that kind limit factor
term comp look comp versu last year potenti that
grow product ye theyv got lot room run type ii
space theyv also win term prefer formulari win
big pbm player
think kind start figur omnipod littl bit newer
space theyv disclos pump sale type ii
insignific growth rate big cgm one im
obvious bullish type ii cgm sinc
start base like im expect type ii pump growth go
like high teen outer year product
roll
travi steed high teen base use million
type ii patient million highlight earlier relat cgm
erik verhoef oh ye definit well million want
use million that fine ye that definit appropri popul need
basal bolu unless want model cequr separ thatd also basal
bolu well that bolu product ye that appropri popul
travi steed alright great dont know bob
anyth els want open question
bob hopkin ye think kind cover last discuss sort
competit landscap pump anyth competitor think
worth mention lookout specif area
erik verhoef think beta bionic one im look theyv theyv rais
lot money last year uniqu approach whether im talk
enter weight drive algorithm importantli
theyr one far enough along dual hormon approach
zealand pharma dasiglucagon that shelf stabl that alway problem
studi
still rememb back think beacon hill studi
three day use didnt count carb walk around go
italian restaur eat whatev want product work realli well
peopl concern alway long-term effect pump
glucagon well see trial data look like theyv
rais money theyr get seriou plan pivot trial
get right could differenti product
term eas use also abil pump two differ hormon
would suspect time rang also go close
partnership option
use either sensor that realli pump competitor time-frame
look would look lilli also pump product dont know much
develop deka group put segway
that also tradit type pump lot data
releas even pictur beta bionic first list
bob hopkin okay great think that time erik erik
want say thank much time today travi obvious thank
help think that go remain someth go
keep super close eye critic market mani compani want
thank everybodi particip call thank erik time im
sure well talk everybodi soon think conclud call thank
erik verhoef alright thank
note confid level /- confid interv instal base number seagrov estim
learn algorithm
analyz patient pattern
cgm valu adjust
appropri set --
input need patient
weight importantli
carb count need
patient
 tz wide recogn
test
algorithm industri
trial patient
 first approv
hybrid close loop system
predict low increas
new guardian sensor
 insulet licens former
algorithm
modifi year
differenti customiz
 formerli known
suspend plg product
use sensor predict
low minut
suspend predict valu
less mg/dl
 univers virginia
 reduct
present ada
 tir
 reduct
 reduct
 increas
 support pma nda
tabl seagrov bluebook summari incom cgm player
plan eu product launch fda studi
file like ce mark obtain novemb non-
adjunct claim issu us commerci expect
target eu launch us launch
earlier year lifescan announc exclus partnership
sanvita develop cgm could avail
select market earli
 eas use consum centric design
 lower cost per day
 earli test mard
 proprietari adhes like skin move bodi
 sensor detect oxygen signal independ glucos
 three reaction chamber detect glucos
 biomed own sanvita recent post job posit cgm medic scientif
 recent patent applic sanvita describ sensor insert devic reduc pain
cgm insert
 patent also describ singl dual lumen cgm latter intend deliveri medic
respons sensor valu
 dimens sensor describ patent inch long inch wide inch
 led ceo markl formerli glumetr
 recent close seri financ fund multipl clinic trial eclips icgm
 next gen system intend extend sensor life year studi
particip complet
 requir wearabl transmitt versu configur electron
implant devic
 day sensor sub mard less calibr
 uniqu electrod system reduc nois interfer
 needle-fre dispos skin patch mard insert non-invas
 uk market launch plan follow select european countri
 claim price pariti test strip
 need replac hour
 minut warm minut interv data read
 requir calibr recharg transmitt
time rang
improv /- hour
less time spent hypo
reduct time spent
hypo rang
reduct time spent
hypo rang
adjust group
differ low glucos
time spent hypo rang
reduc
less time
time hyperglycemia
less time spent
tabl seagrov bluebook summari incom cgm player
eu distribut plan product alreadi ce
plan use de-novo pathway us clearanc
like
compar continu flash
glucos monitor adult type
continu monitor control
studi pediatr patient
evalu implant
continu glucos sensor
perform evalu
advanc algorithm cgm
adult adolesc pediatr
medtron guardian sensor
day use
 collect product featur
 score realli well hcp market
 paq meal
nice design bolus-onli
 lilli readi pivot move
quicker expect
focu pen first
 depriorit push back
us diabet popul
number type patient
tabl seagrov bluebook unit state estim therapi type mm patient
number type patient
chart seagrov bluebook type type diabet pop
chart seagrov bluebook type diabet preval geographi
million patient
chart seagrov bluebook type diabet preval geographi
million patient
chart seagrov bluebook rapid act insulin patient patient million
valu ev/sal given compani trade revenu growth
price object base revenu estim multipl line
small mid-cap med-tech compani similar revenu growth rate
market opportun
upsid risk strateg activ patient expect less impact
expect competit faster approv pipelin product
downsid risk price pressur fewer patient added/high attrit current
patient due competitor threat lack patient want adopt cgm delay
pipelin product
travi steed herebi certifi view express research report accur
reflect person view subject secur issuer also certifi
part compens directli indirectli relat specif
recommend view express research report
becton dickinson compani
qualiti earn
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
